Matched Paired Pharmacodynamics and Feasibility Study of Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Therapeutic Use
- 05 Jul 2016 Planned primary completion date changed from 1 Aug 2019 to 1 Jul 2019.
- 05 Jul 2016 Status changed from not yet recruiting to recruiting.
- 10 May 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Aug 2019.